About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Two Investigational Antitumor Agents Efficacious Against a Rare Pediatric Cancer

by Dr. Trupti Shirole on February 14, 2017 at 5:06 PM
Font : A-A+

 Two Investigational Antitumor Agents Efficacious Against a Rare Pediatric Cancer

Malignant peripheral nerve sheath tumor (MPNST) is a rare pediatric cancer.  For patients with neurofibromatosis 1, a genetic cancer predisposition disorder, MPNST is the leading cause of death. More importantly, MPNST is resistant to chemotherapy.

Two investigational agents, Aurora A kinase inhibitor (alisertib) and HSV1716, a virus derived from HSV-1 and attenuated by the deletion of RL1, have shown some antitumor efficacy in early clinical trials as monotherapies.

Advertisement


A new study published last week in Oncotarget, however, demonstrates that the combined usage of the agents results in significantly increased antitumor efficacy in models of malignant peripheral nerve sheath tumor (MPNST) and neuroblastoma.

"We chose to investigate this combination in MPNST and neuroblastoma because these are two difficult-to-treat sarcomas that have shown susceptibility to these agents individually," explains Timothy Cripe, division chief of Hematology/Oncology & BMT at Nationwide Children's Hospital and senior author on the study.
Advertisement

According to Dr. Cripe, who is also a principal investigator in the Center for Childhood Cancer and Blood Diseases in The Research Institute at Nationwide Children's, many mechanisms likely worked synergistically to increase the antitumor effect in this study. Particularly, HSV1716 increased the sensitivity of uninfected cells to alisertib cytotoxicity.

Second, alisertib increased peak virus production and slowed virus clearance from tumors. The team also found that alisertib inhibited virus-induced accumulation of intratumoral myeloid derived suppressor cells.

"Our study shows that alisertib helps the infection phase of HSV1716 because innate immunity is impacted," says Dr. Cripe, also professor of Pediatrics at The Ohio State University College of Medicine. "It's possible that it could inhibit the second phase, the downstream immunotherapeutic effects of the virotherapy, but based on data from other studies, we don't think that is the case."

Moving forward, Dr. Cripe says that confirming the sustained immunotherapeutic benefits of HSV1716 in the presence of alisertib and building a clinical trial are important next steps in understanding how these agents work together and how they could impact care for patients.

"Our results, in the context of early trials of both substances individually that have shown safety and efficacy, support the testing of this combination in children and young adults with neuroblastoma and MPNST," says Dr. Cripe. "As these agents continue to move through the development and approval processes, we look forward to studying them further."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Amyotrophic Lateral Sclerosis (ALS) Pediatric Pyloric Stenosis Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant 

Recommended Reading
FL118 Demonstrates Potent Antitumor Efficacy
A research team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park Cancer Institute ......
Potential Alternative Drug Therapies for Neuroblastoma Uncovered
Nearly two-thirds of patients with high-risk neuroblastoma cannot be cured using tumor-killing ......
Researchers Identify a New Strategy for Treating Neuroblastoma
At Duke Medicine, researchers have identified a new strategy for treating neuroblastoma using a ......
Researchers Find New Ways to Treat Neuroblastoma
In the brain, loss of a gene required for stem cells to turn into neurons may underlie the most ......
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis....
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Pediatric Pyloric Stenosis
Pyloric stenosis in a child is narrowing of the pylorus due to which the milk cannot pass into the s...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)